$ZVRA
ZEVRA THERAPEUTICS, INC.

2019 Q2 Form 10-Q Financial Statement

#000143774919016596 Filed on August 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.990M $3.420M
YoY Change -12.57% -4.2%
% of Gross Profit
Research & Development $4.803M $10.49M
YoY Change -54.2% 125.55%
% of Gross Profit
Depreciation & Amortization $70.00K $90.00K
YoY Change -22.22% 12.5%
% of Gross Profit
Operating Expenses $7.792M $13.91M
YoY Change -43.97% 69.11%
Operating Profit -$7.792M -$13.91M
YoY Change -43.97% 69.11%
Interest Expense $1.232M $1.419M
YoY Change -13.18% -1.66%
% of Operating Profit
Other Income/Expense, Net -$1.474M $3.876M
YoY Change -138.03% 127.6%
Pretax Income -$9.266M -$10.03M
YoY Change -7.64% 53.84%
Income Tax -$9.000K -$39.00K
% Of Pretax Income
Net Earnings -$9.257M -$9.993M
YoY Change -7.37% 53.34%
Net Earnings / Revenue
Basic Earnings Per Share -$0.33 -$0.65
Diluted Earnings Per Share -$0.33 -$0.91
COMMON SHARES
Basic Shares Outstanding 28.39M 15.32M
Diluted Shares Outstanding 28.39M 16.55M

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.300M $28.20M
YoY Change -74.11% -47.29%
Cash & Equivalents $7.308M $16.50M
Short-Term Investments $0.00 $11.70M
Other Short-Term Assets $1.300M $2.700M
YoY Change -51.85% 42.11%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.640M $30.91M
YoY Change -72.05% -44.17%
LONG-TERM ASSETS
Property, Plant & Equipment $1.613M $1.841M
YoY Change -12.38% -14.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $548.0K $1.250M
YoY Change -56.16% 289.41%
Total Long-Term Assets $4.369M $3.091M
YoY Change 41.35% -77.41%
TOTAL ASSETS
Total Short-Term Assets $8.640M $30.91M
Total Long-Term Assets $4.369M $3.091M
Total Assets $13.01M $34.00M
YoY Change -61.74% -50.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.900M $14.00M
YoY Change -43.57% 122.22%
Accrued Expenses $400.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.700M $3.500M
YoY Change 91.43% 1650.0%
Total Short-Term Liabilities $14.98M $17.60M
YoY Change -14.93% 167.04%
LONG-TERM LIABILITIES
Long-Term Debt $75.80M $87.30M
YoY Change -13.17% -5.11%
Other Long-Term Liabilities $296.0K $743.0K
YoY Change -60.16% -49.52%
Total Long-Term Liabilities $296.0K $743.0K
YoY Change -60.16% -49.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.98M $17.60M
Total Long-Term Liabilities $296.0K $743.0K
Total Liabilities $94.56M $117.5M
YoY Change -19.56% 8.51%
SHAREHOLDERS EQUITY
Retained Earnings -$242.7M -$200.9M
YoY Change 20.8% 39.37%
Common Stock $161.2M $117.4M
YoY Change 37.31% 11.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$81.55M -$83.55M
YoY Change
Total Liabilities & Shareholders Equity $13.01M $34.00M
YoY Change -61.74% -50.76%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$9.257M -$9.993M
YoY Change -7.37% 53.34%
Depreciation, Depletion And Amortization $70.00K $90.00K
YoY Change -22.22% 12.5%
Cash From Operating Activities -$7.340M -$9.150M
YoY Change -19.78% 41.42%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $15.68M
YoY Change -100.0% 157.89%
Cash From Investing Activities $0.00 $15.68M
YoY Change -100.0% 159.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.180M 1.220M
YoY Change -3.28% -2133.33%
NET CHANGE
Cash From Operating Activities -7.340M -9.150M
Cash From Investing Activities 0.000 15.68M
Cash From Financing Activities 1.180M 1.220M
Net Change In Cash -6.160M 7.750M
YoY Change -179.48% -1681.63%
FREE CASH FLOW
Cash From Operating Activities -$7.340M -$9.150M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$7.340M -$9.150M
YoY Change -19.78% 42.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
11000
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
163000
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
251000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
61000
CY2019Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.077
CY2019Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
128000
CY2019Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
47000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
104000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
CY2019Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
30000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17000
CY2019Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2989000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3420000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5827000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6552000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9266000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10032000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21565000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36259000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2399000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4063000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-47000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-788000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-51000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-734000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1030000
CY2019Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
84000
CY2018Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
123000
us-gaap Interest And Other Income
InterestAndOtherIncome
235000
CY2018Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
79000
CY2018Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1152000
CY2018Q2 us-gaap Interest Expense
InterestExpense
1419000
us-gaap Interest Expense
InterestExpense
2461000
us-gaap Interest Expense
InterestExpense
2861000
CY2018Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
409000
us-gaap Interest Paid Net
InterestPaidNet
2455000
us-gaap Interest Paid Net
InterestPaidNet
2863000
us-gaap Interest And Other Income
InterestAndOtherIncome
238000
CY2019Q2 us-gaap Interest Expense
InterestExpense
1232000
CY2019Q2 us-gaap Lease Cost
LeaseCost
204000
us-gaap Lease Cost
LeaseCost
417000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3070000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
903000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
472000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
461000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
449000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
499000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
286000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
628000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12004000
CY2019Q2 us-gaap Liabilities
Liabilities
94556000
CY2018Q4 us-gaap Liabilities
Liabilities
93312000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13009000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26746000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14975000
CY2019Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2019Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
CY2018Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15122000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1474000
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3260000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3846000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3966000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3243000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24911000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18410000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23251000
us-gaap Net Income Loss
NetIncomeLoss
-21548000
us-gaap Net Income Loss
NetIncomeLoss
-36212000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-9257000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-9993000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-26219000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-12291000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9993000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
7792000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
13908000
us-gaap Operating Expenses
OperatingExpenses
19161000
us-gaap Operating Expenses
OperatingExpenses
28677000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3876000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2404000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7582000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13908000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19161000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7792000
us-gaap Operating Income Loss
OperatingIncomeLoss
-28677000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
124000
us-gaap Operating Lease Cost
OperatingLeaseCost
248000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
394000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2048000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
us-gaap Operating Lease Payments
OperatingLeasePayments
217000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1718000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2442000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
548000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
562000
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
222000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2018Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
9577
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3337
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
115000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
296000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
689000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3992000
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3337
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1332000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2052000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3260000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24911000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
68000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3950000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1753000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
94000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1613000
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2018Q1 kmph Adjustment To Additional Paid In Capital Writeoff Of Deferred Offering Costs
AdjustmentToAdditionalPaidInCapitalWriteoffOfDeferredOfferingCosts
-27000
CY2018Q2 kmph Adjustment To Additional Paid In Capital Writeoff Of Deferred Offering Costs
AdjustmentToAdditionalPaidInCapitalWriteoffOfDeferredOfferingCosts
-11000
CY2019Q1 kmph Adjustment To Additional Paid In Capital Writeoff Of Deferred Offering Costs
AdjustmentToAdditionalPaidInCapitalWriteoffOfDeferredOfferingCosts
10000
kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
105000
kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
kmph Deferred Offering Costs Writeoff
DeferredOfferingCostsWriteoff
10000
kmph Deferred Offering Costs Writeoff
DeferredOfferingCostsWriteoff
CY2019Q2 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
1686000
CY2018Q4 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
2118000
CY2018Q2 kmph Fair Value Adjustment Of Put Option Net Of Tax
FairValueAdjustmentOfPutOptionNetOfTax
-2923000
CY2018Q2 kmph Fair Value Adjustment Of Warrants Net Of Tax
FairValueAdjustmentOfWarrantsNetOfTax
-2615000
CY2019Q2 kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
-16000
CY2018Q2 kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
5562000
kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
408000
kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
-4179000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001434647
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29758543
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
kmph
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
KEMPHARM, INC
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018Q4 kmph Sale Of Securities Covered Under Prospectus Supplement Value Anticipated Amount To Be Sold Under Registration Statement
SaleOfSecuritiesCoveredUnderProspectusSupplementValueAnticipatedAmountToBeSoldUnderRegistrationStatement
18500000
CY2018Q4 kmph Sale Of Securities Covered Under Prospectus Supplement Value Anticipated Sales Under Atm Agreement
SaleOfSecuritiesCoveredUnderProspectusSupplementValueAnticipatedSalesUnderATMAgreement
3200000
CY2018Q4 kmph Sale Of Securities Covered Under Prospectus Supplement Value Anticipated Sales Under Purchase Agreement
SaleOfSecuritiesCoveredUnderProspectusSupplementValueAnticipatedSalesUnderPurchaseAgreement
15300000
CY2018Q4 kmph Sale Of Securities Value Available To Issue
SaleOfSecuritiesValueAvailableToIssue
150000000
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7862000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8342000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
161190000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
154623000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
3502000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1281000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1378000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1290000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1317000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1317000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1380000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2607000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2659000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1919000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2195000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
610000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
780000
CY2019Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
305000
CY2018Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14250964
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8828596
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14250964
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11899797
CY2019Q2 us-gaap Assets
Assets
13009000
CY2018Q4 us-gaap Assets
Assets
26746000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
8640000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
23721000
CY2019Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14510083
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
13641913
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28858543
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26455352
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28858543
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26455352
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27976823
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2019Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
75551000
CY2018Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
78105000
CY2019Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
6497000
CY2018Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3333000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3502000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
153000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
166000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.41
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.41
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-432000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4179000
CY2019Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
21000
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5562000
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1421000
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
17450000
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1845000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7709000
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1437000
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11888000
CY2019Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
22000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
22000
CY2019Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
506000
CY2019Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
553000
CY2019Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1852000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4803000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10488000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13334000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22125000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
490000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
710000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242740000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-221192000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
737000
us-gaap Share Based Compensation
ShareBasedCompensation
2607000
us-gaap Share Based Compensation
ShareBasedCompensation
2659000
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
58000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
115000
us-gaap Short Term Lease Payments
ShortTermLeasePayments
115000
CY2019Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
81720
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22375
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23682
CY2019Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2798000
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1194000
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2721000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1229000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
68000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-81547000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-66566000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-57516000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-79683000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-83545000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-74836000
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
25000
us-gaap Sublease Income
SubleaseIncome
50000
CY2018Q2 us-gaap Undistributed Earnings
UndistributedEarnings
-9993000
CY2018Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28386119
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16548751
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP&nbsp;requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">On an ongoing basis, the Company evaluates its estimates, including those related to the useful lives of property and equipment, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div></div></div>
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
6000
us-gaap Variable Lease Cost
VariableLeaseCost
21000
us-gaap Variable Lease Payment
VariableLeasePayment
21000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27548657
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15056161
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28386119
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15317536
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27548657
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15056161
CY2019Q2 kmph Finance Lease Cost Total
FinanceLeaseCostTotal
41000
kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
3000
kmph Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2442000
kmph Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
kmph Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
1718000
kmph Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
CY2019Q1 kmph Increase In Common Stock Reserved For Issuance
IncreaseInCommonStockReservedForIssuance
1058214
kmph Finance Lease Cost Total
FinanceLeaseCostTotal
83000
kmph Lessee Lease Option To Extend Maximum Term
LesseeLeaseOptionToExtendMaximumTerm
P5Y
kmph Lessee Lease Option To Terminate Term
LesseeLeaseOptionToTerminateTerm
P1Y
CY2019Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
CY2018Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
214000
CY2019Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7798000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17597000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11321000
CY2018Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
396000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7308000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18409000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19119000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11971000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5626000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies

Files In Submission

Name View Source Status
0001437749-19-016596-index-headers.html Edgar Link pending
0001437749-19-016596-index.html Edgar Link pending
0001437749-19-016596.txt Edgar Link pending
0001437749-19-016596-xbrl.zip Edgar Link pending
ex_149623.htm Edgar Link pending
ex_149624.htm Edgar Link pending
ex_149625.htm Edgar Link pending
ex_149626.htm Edgar Link pending
ex_154024.htm Edgar Link pending
ex_154025.htm Edgar Link pending
ex_154026.htm Edgar Link pending
ex_154027.htm Edgar Link pending
ex_154028.htm Edgar Link pending
ex_154029.htm Edgar Link pending
ex_154030.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kmph-20190630.xml Edgar Link completed
kmph-20190630.xsd Edgar Link pending
kmph-20190630_cal.xml Edgar Link unprocessable
kmph-20190630_def.xml Edgar Link unprocessable
kmph-20190630_lab.xml Edgar Link unprocessable
kmph-20190630_pre.xml Edgar Link unprocessable
kmph20190630_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending